Setmelanotide is an effective medication for the disease of obesity in patients older than 6 years if the patient has POMC deficiency, PCSK1 deficiency, LEPR deficiency, or Bardet–Biedl syndrome [21,38,39,40]. Here, POMC is linked to obesity disorder.